OSTO:GETI B (Sweden)
Business Description
Getinge AB
NAICS : 339112
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Compare
Compare
Traded in other countries / regions
GTN.Germany
•
GETIB.Mexico
•
GETI B.Sweden
•
0GZV.UK
•
GNGBF.USA
Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (57% of revenue), surgical workflows (30%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.77 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | 0.97 | |||||
| Interest Coverage | 23.94 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.57 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.8 | |||||
| 3-Year EBITDA Growth Rate | 56.6 | |||||
| 3-Year FCF Growth Rate | 71.1 | |||||
| 3-Year Book Growth Rate | 8.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 3.24 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.76 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.13 | |||||
| 9-Day RSI | 39.66 | |||||
| 14-Day RSI | 39.49 | |||||
| 6-1 Month Momentum % | -31.87 | |||||
| 12-1 Month Momentum % | -34.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.96 | |||||
| Quick Ratio | 4.44 | |||||
| Cash Ratio | 1.76 | |||||
| Days Inventory | 136.04 | |||||
| Days Sales Outstanding | 56.2 | |||||
| Days Payable | 47.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.81 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 1.81 | |||||
| 5-Year Yield-on-Cost % | 1.7 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.91 | |||||
| Operating Margin % | 13.67 | |||||
| Net Margin % | 9.82 | |||||
| ROE % | 10.7 | |||||
| ROA % | 5.96 | |||||
| ROIC % | 6.9 | |||||
| ROC (Joel Greenblatt) % | 31.83 | |||||
| ROCE % | 9.31 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.73 | |||||
| Forward PE Ratio | 18.98 | |||||
| PE Ratio without NRI | 22.55 | |||||
| Shiller PE Ratio | 30.6 | |||||
| Price-to-Owner-Earnings | 20.88 | |||||
| PEG Ratio | 1.94 | |||||
| PS Ratio | 2.23 | |||||
| PB Ratio | 2.18 | |||||
| Price-to-Tangible-Book | 42.34 | |||||
| Price-to-Free-Cash-Flow | 19.62 | |||||
| Price-to-Operating-Cash-Flow | 14.64 | |||||
| EV-to-EBIT | 17.4 | |||||
| EV-to-Forward-EBIT | 14.96 | |||||
| EV-to-EBITDA | 11.8 | |||||
| EV-to-Forward-EBITDA | 10.58 | |||||
| EV-to-Revenue | 2.43 | |||||
| EV-to-Forward-Revenue | 2.32 | |||||
| EV-to-FCF | 21.17 | |||||
| Price-to-Projected-FCF | 1.14 | |||||
| Price-to-Median-PS-Value | 1.36 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.97 | |||||
| Price-to-Graham-Number | 6.54 | |||||
| Earnings Yield (Greenblatt) % | 5.74 | |||||
| Forward Rate of Return (Yacktman) % | 25.28 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 27,146 | ||
| EPS (TTM) (kr) | 9.78 | ||
| Beta | 1.34 | ||
| Volatility % | 31.17 | ||
| 14-Day RSI | 39.49 | ||
| 14-Day ATR (kr) | 7.365107 | ||
| 20-Day SMA (kr) | 228.805 | ||
| 12-1 Month Momentum % | -34.65 | ||
| 52-Week Range (kr) | 203.7 - 431.6 | ||
| Shares Outstanding (Mil) | 272.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Getinge AB Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||